Definition of patients treated with evidence based drugs in absence of prescribed daily doses: The example of acute myocardial infarction

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 2, 2011, Pages 169-176

  Belleudi, Valeria ^a   Fusco, Danilo ^a   Kirchmayer, Ursula ^a   Agabiti, Nera ^a   Di Martino, Mirko ^a   Narduzzi, Silvia ^a   Davoli, Marina ^a   Arcà, Massimo ^a   Perucci, Carlo Alberto ^a  

^a Department of Epidemiology ^*  (Italy)

Author keywords

Adherence measures; Drug therapy; Drug use; Myocardial infarction; Poly therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ARTICLE; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; ROME; TIME FACTORS;

EID: 78751690600     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2079     Document Type: Article

References (40)

1. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-574.
2. Kopjar B, Sales AE, Piñeros SL, Li YF, Hedeen AN. Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population. Am J Cardiol 2003; 92: 1106-1108.
3. Tuppin P, Neumann A, Danchin N, et al. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database. Arch Cardiovasc Dis 2009; 102: 279-292.
4. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297: 177-186.
5. Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank V. Trends in adherence to secondary prevention medication in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2008; 17: 1189-1196.
6. Johnson ES, Mozaffari E. Measuring patient persistency with drug therapy using methods for the design and analysis of natural history studies. Am J Manag Care 2002; 8: 249-254.
7. Gislason GH, Rasmussen JN, Abildstrøm SZ, et al. Long-term compliance with beta.blockers Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006; 27: 1153-1158.
8. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity and applications. J Clin Epidemiol 1997; 50: 105-116.
9. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009; 25: 2303-2310.
10. Bryson CL, Au DH, Young B, Mc Donell MB, Fihn SD. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care 2007; 45: 497-504.
11. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009; 43: 413-422.
12. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846-857.
13. McKenzie DA, Semradek J, McFarland BH, Mellody JP, Mc Camant LE. The validity of medicaid pharmacy claims for estimating drug use among elderly nursing home residents: the Oregon experience. J Clin Epidemiol 2000; 53: 1248-1257.
14. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 2006; 44: 471-477.
15. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008; 46: 1125-1133.
16. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006; 40: 1280-1288.
17. National Institute of Statistics (ISTAT). Italy. Available at: [Accessed on 12 February 2009].
18. Vink NM, Klungel OH, Stolk RP, Denig P. Comparison of various measures for assessing medication refill adherence using prescribed data. Pharmacoepidemiol Drug Saf 2009; 18: 159-165.
19. Mazzaglia G, Ambrosini E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1558-1560.
20. Di Martino M, Veronesi C, Degli Esposti L, et al. Adherence to anttihypertensive drug treatment and blood pressure control: a real practice analysis in Italy. J Hum Hyperten 2008; 22: 51-53.
21. Poluzzi E, Strahinja P, Lanzoni M, et al. Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological stusy in Italy. Eur J Clin Pharmacol 2008; 64: 425-432.
22. Gruppo di lavoro OsMed. L'uso dei farmaci in Italia. Rapporto nazionale anno 2008. Roma: Il Pensiero Scientifico Editore, 2009.
23. Sturkenboom M, Verhamme K, Nicolosi A, et al. Drug use in children: cohort study in European countries. BMJ 2008; 24: 337.
24. Maio V, Yuen E, Rabinowitz C, et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy 2005; 10: 232-238.
25. NICE. Myocardial infarction: secondary prevention. Clinical Guideline, Vol. 48, 2007. Available at: [Accessed on 14 January 2010].
26. Marandi T, Baburin A, Ainla T. Use of evidence-based pharmacotherapy after myocardial infarction in Estonia. BMC Public Health 2010; 10: 358.
27. Bergman U. The history of the drug utilization research group in Europe. Pharmacoepidemiol Drug Saf 2006; 15: 95-98.
28. Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006; 28: 1411-1424.
29. De With K, Bestehorn H, Steib-Bauert M. Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection 2009; 37: 349-352.
30. Lucioni C, Mazzi S, Pari B, et al. L'utilizzo delle DDD refernce based per la valutazione della compliance terapeutica nel trattamento con statine. PharmacoEconomics 2008; 10: 77-88.
31. Grimmsmann T, Himmel W. Relation between defined daily doses (DDD) and prescibed daily doses: a 3-month analysis of outpatient data from a statutory health insurance company. Gesundheitswesen 2009; 20.
32. Cook CL, Wade WE, Martin BC, Perri M. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc 2005; 45: 151-159.
33. Guénette L, Moisan J, Préville M, Boyer R. Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records. J Clin Epidemiol 2005; 58: 924-933.
34. Choundhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009; 15: 457-464.
35. Crilly M, Bundred P, Hu X, Leckey L, Johnstone F. Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary care. BMC Health Serv Res 2007; 7: 142.
36. Yan AT, Yan RT, Tan M, et al., Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J 2007; 154(6): 1108-1115 (Epub 14 September 2007).
37. Lee JH, Yang DH, Park HS, et al., Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J 2010; 159(6): 1012-1019.
38. Bi Y, Gae R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the clinical pathways for acute coronary syndromes in China (CPACS) study. Am Heart J 2009; 157: 509-516.
39. Vermeer NS, Bajorek BV. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. J Clin Pharm Ther 2009; 38: 156-162.
40. Fox KA, Goodman SG, Anderson FA, Jr, et al., From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24(15): 1414-1424.